CDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Mirikizumab study Dr. Divya Colin30 Dec 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
ELi Lilly Omvoh recommended by CHMP for approval in EU for adults with moderately to severely active Crohn's disease Ruchika Sharma14 Dec 2024 10:30 AM ISTIndianapolis: Eli Lilly and Company has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for...
Eli Lilly Gets CDSCO Panel Nod To Market Mirikizumab for ulcerative colitis in adults Dr. Divya Colin7 April 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got marketing authorization from the Subject Expert Committee (SEC) functional under the Central Drug...
Eli Lilly Mirikizumab helps patients with Crohn's Disease achieve long-term Remission in Phase 3 trial Ruchika Sharma15 Oct 2023 12:30 PM ISTIndianapolis: Eli Lilly and Company has announced that mirikizumab (an investigational interleukin-23p19 antagonist) has met the co-primary...
Mirikizumab Highly Effective in Treating Ulcerative Colitis and safely Maintaining Remission: NEJM Aditi2 July 2023 8:00 PM ISTAn original article entitled "Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis", published in the New England Journal of...
Eli Lilly bowel disease drug Mirikizumab rejected by USFDA Ruchika Sharma14 April 2023 3:00 PM ISTThe health regulator cited issues related to the proposed manufacturing of the drug mirikizumab.
Mirikizumab efficacy to placebo for treating moderate-to-severe plaque psoriasis Medha Baranwal3 Jan 2023 8:00 PM ISTUSA: Interleukin (IL)-23 and IL-17 are known to play critical roles in the development of psoriatic disease, so therapies targeting these cytokines...
Eli Lilly hopes to launch as many as 5 new treatments next year Ruchika Sharma14 Dec 2022 3:15 PM ISTIndianapolis: Eli Lilly and Co said on Tuesday it hopes to launch as many as five new treatments next year that could drive growth through the decade...
Continued Treatment With Mirikizumab effective in Patients With Ulcerative Colitis: Study Dr. Shravani Dali2 Feb 2022 9:00 AM ISTExtended doses (600 and 1000 mg) of mirikizumab effective in Phase 2 Trial of Patients with Ulcerative Colitis, according to a recent study...
